Physiology of Puberty

Definition & Scope

  • Adolescence (WHO):

    • Period between 10–19  years10\text{–}19\;\text{years}.

    • Transitional span in which an individual moves from dependence ➞ autonomy ➞ maturity.

    • Shift in social role: family–centred child ➞ peer-oriented youth ➞ self-standing adult.

  • Puberty (Lat. “pubertas” = age of manhood):

    • Sub-phase (≈ 2–5  yrs2\text{–}5\;\text{yrs}) within adolescence.

    • Marks physiological capability of reproduction by complete maturation of the gonads & external genitalia.

    • Characterised by:

    • Rapid increase in height, weight, strength ("growth spurt").

    • Development of secondary sexual characteristics.

    • Profound psychosocial changes (identity, autonomy, sexuality).

    • Average onset: ≈11  yrs (girls),  13  yrs (boys)\approx 11\;\text{yrs (girls)},\;13\;\text{yrs (boys)} (wide normal variation).

Domains of Adolescent Development

  • Biological (physiological, physical, sexual maturation).

  • Cognitive (abstract thinking, decision-making).

  • Psychological (self-esteem, emotional lability).

  • Social (peer affiliation, role experimentation).

  • Moral & Spiritual (value formation, responsibility for actions).

Age-Linked Responsibilities (illustrative cultural / ethical framing)

  • 7–10  yrs7\text{–}10\;\text{yrs}: Learn etiquette eg. asking permission before entering parents’ room.

  • 10–16  yrs10\text{–}16\;\text{yrs}: Guided introduction to inter-gender interaction & sexual conduct.

  • >16\;\text{yrs}: Full accountability for choices (e.g.
    pre-marital abstinence, avoidance of adultery/fornication).

Human Sexuality – Conceptual Overview

  • Encompasses the ways a person experiences & expresses gender/sexual orientation.

  • Central to identity & sense of self.

  • Improved by accurate knowledge of pubertal physiology ➞ healthier attitudes & behaviours.

Two Inter-related Streams of Pubertal Change

  1. Physical Manifestations

    • Male:

      • Gonadarche → testicular enlargement.

      • Spermache → first ejaculation containing spermatozoa.

    • Female:

      • Gonadarche → ovarian growth & steroidogenesis.

      • Thelarche → post-natal breast development.

      • Menarche → first menses.

  2. Hormonal Cascade

    • Progressive maturation of the Hypothalamic–Pituitary–Gonadal (HPG) axis (also HPO in females).

Steroidogenesis Snapshot (Adrenal Cortex)

  • Cholesterol enters mitochondria via StAR protein.

  • Core enzymatic steps (cortisol pathway):
    Cholesterol→20,22  desmolasePregnenolone<br>→17α-OH17α-Hydroxypregnenolone<br>→3β-HSD17α-Hydroxyprogesterone<br>→21-OH11-Deoxycortisol<br>→11β-OHCortisol\text{Cholesterol}\xrightarrow{20,22\;\text{desmolase}}\text{Pregnenolone}<br>\xrightarrow{17\alpha\text{-OH}}17\alpha\text{-Hydroxypregnenolone}<br>\xrightarrow{3\beta\text{-HSD}}17\alpha\text{-Hydroxyprogesterone}<br>\xrightarrow{21\text{-OH}}11\text{-Deoxycortisol}<br>\xrightarrow{11\beta\text{-OH}}\text{Cortisol}

  • Key P450 enzymes: CYP17,CYP21,CYP11B1,CYP11B2CYP17, CYP21, CYP11B1, CYP11B2; zones: glomerulosa (aldosterone), fasciculata (cortisol), reticularis (androgens).

Tanner (Marshall-Tanner) Sexual Maturity Rating

  • Objectifies progression via 5 stages (I–V) based on:

    • Breast (B1–B5) & genital size (G1–G5 / testicular volume >4  mL4\;\text{mL} signals Stage II).

    • Pubic & axillary hair (P1–P5).

  • Sequence is fixed; timing varies (heritable 50–80%).

Typical Chronology of Events (Approximate)

Girls

  • 8→11  yrs8\rightarrow11\;\text{yrs} – Thelarche.

  • Pubic hair soon after.

  • Peak height velocity ≈11–12  yrs≈11\text{–}12\;\text{yrs}.

  • Menarche ≈12.5  yrs≈12.5\;\text{yrs} (range 10–16) after
    ∼!2  yrs\sim!2\;\text{yrs} of breast budding.

  • Under-arm hair, body contour change ➞ adult pattern.

Boys

  • 9→12  yrs9\rightarrow12\;\text{yrs} – Increase in testicular volume.

  • Pubic hair, penile lengthening, scrotal thinning.

  • Voice deepening (laryngeal growth).

  • Peak height velocity ≈13–14  yrs≈13\text{–}14\;\text{yrs}.

  • Facial & axillary hair, spermarche.

HPG Axis – "Turning On" Puberty

  • Hypothalamus: pulsatile GnRH secretion (≈ every 60–120 min at night).

    • Switched on by Neurokinin-B (NKB) & Kisspeptin neurons.

    • Modulated by Leptin (fat-derived; signals energetic sufficiency).

  • Anterior Pituitary Gonadotropes: release LH & FSH.

    • LH acts on Leydig (testes) / Theca (ovary) cells ➞ androgen production.

    • FSH acts on Sertoli (testes) / granulosa (ovary) cells ➞ gametogenesis & aromatase activity.

  • Gonads: secrete Testosterone, Estradiol, Inhibin ➞ feedback to hypothalamus & pituitary.

  • Feedback loops: predominantly negative feedback via sex steroids & inhibin; cyclical positive feedback (E2 → LH surge) appears only after full maturation.

Cross-Axis Interactions

  • HPA (stress) & HPT (thyroid) axes interact via glucocorticoids (GC), thyroid hormones (TH) & GnIH (gonadotropin-inhibitory hormone) causing suppression or modulation of HPG output.

  • Clinical relevance: chronic stress, Cushing’s, or hypothyroidism can delay puberty.

Determinants of Puberty Timing

  • Genetics: heritability ≈50–80%≈50\text{–}80\%.

  • Nutrition & energy balance (malnutrition, anorexia, obesity ➞ leptin changes).

  • Environmental endocrine disruptors (e.g. bisphenol-A, phthalates, pesticides).

  • Chronic diseases (e.g. cystic fibrosis, chronic renal failure).

  • Social stressors (e.g. sustained child abuse) – may hasten onset.

  • Body weight & body fat threshold (girls need ≈17%\approx17\% body fat for menarche).

Anomalies of Puberty – Precocious Puberty (PP)

  • Definition: Onset <8  yrs8\;\text{yrs} girls / <9  yrs9\;\text{yrs} boys.

  • Warning signs:

    • Breast development <8 yrs or menarche <10 yrs.

    • Testicular volume >3  mL3\;\text{mL} before 9 yrs.

    • Pubic hair <8 yrs (girls) or <9 yrs (boys).

1. Central (True, GnRH-dependent) Precocious Puberty – CPP

  • Follows normal HPG sequence (Tanner-consistent).

  • 80–90%80\text{–}90\% idiopathic, esp. girls.

  • CNS causes (<20%):

    • Tumours: hypothalamic hamartoma, optic glioma, craniopharyngioma, germinomas, ependymoma.

    • CNS insults: hydrocephalus, trauma, radiotherapy, infection.

    • Congenital malformations: septo-optic dysplasia.

2. Peripheral (GnRH-independent) Precocious Puberty – PPP

  • Partial or dissociated development; does NOT start with GnRH pulse.

  • Aetiologies:

    • Exogenous sex steroids / gonadotropins.

    • hCG-secreting tumours (teratoma, hepatoblastoma).

    • Ovarian cysts, granulosa cell tumours; Leydig cell tumours.

    • Adrenal tumours / hyperplasia.

    • Congenital Adrenal Hyperplasia (CAH).

    • McCune-Albright Syndrome (MAS).

Congenital Adrenal Hyperplasia (21-Hydroxylase Deficiency)

  • Loss of 21-OH21\text{-OH} ➞ ↓cortisol & ↓aldosterone ➞ ↑ACTH ➞ adrenal hyperplasia ➞ ↑androgens.

  • Clinical: virilisation of females (clitoral enlargement, ambiguous genitalia), salt-wasting crises.

  • Pathway block diagram (simplified):
    Progesterone→21-OH11-DOC    (blocked)\text{Progesterone}\xrightarrow{21\text{-OH}}\text{11-DOC} \;\;\text{(blocked)}

  • Variant: Lipoid CAH (StAR defect) – severe deficiency of all steroids; delayed puberty.

McCune-Albright Syndrome

  • Activating mutation in GNAS1 (α-subunit of Gs protein).

  • Triad: café-au-lait skin, polyostotic fibrous dysplasia, endocrine hyperfunction (precocious puberty, hyperthyroidism, GH excess, Cushing’s).

  • Girls: menstrual bleeding by age 2 due to ovarian cyst–derived oestrogen.

Anomalies of Puberty – Delayed Puberty

  • Definition: No pubertal signs by 13  yrs13\;\text{yrs} (girls) / 14  yrs14\;\text{yrs} (boys); no menarche by 15  yrs15\;\text{yrs}.

  • Screening clues:

    • Breast stage <B2, testicular volume <4  mL4\;\text{mL}, or genitalia stage G1 after cutoff ages.

1. Normogonadotropic (Eugonadotropic) Hypogonadism

  • Normal LH/FSH (5–20 IU/L); intact HPG axis but outflow/target problem.

  • Primary amenorrhoea causes:

    • Mullerian agenesis (15%).

    • Outflow obstruction: transverse vaginal septum, imperforate hymen (5%).

    • Uterine/pituitary disorders, PCOS, androgen insensitivity, mild CAH.

2. Hypergonadotropic Hypogonadism (Primary Gonadal Failure)

  • High LH/FSH; gonads unresponsive.

  • Congenital:

    • Turner (45,X0) – streak ovaries, short stature, webbed neck.

    • Klinefelter (47,XXY) – tall, gynecomastia, small testes.

    • Complete androgen insensitivity (46,XY ➞ phenotypic female).

  • Acquired:

    • Chemo/radiotherapy, surgery.

    • Post-infectious (mumps orchitis), torsion.

    • Autoimmune polyglandular syndromes.

    • “Vanishing testes”; “Resistant ovary” (gonadotropin receptor defect).

3. Hypogonadotropic Hypogonadism (Secondary)

  • Low/normal LH & FSH; hypothalamic/pituitary failure.

  • Causes:

    • Constitutional delay of growth & puberty (most common; self-limited).

    • Chronic malnutrition, excessive exercise, GH deficiency.

    • Isolated GnRH deficiency – Kallmann Syndrome:

    • Incidence 1:10,000 males; anosmia/hyposmia.

    • Mutation in KAL-1 (anosmin) disrupts GnRH neuron migration.

    • May co-present with cleft palate, deafness.

    • CNS tumours: craniopharyngioma, astrocytoma, glioma, germinoma, prolactinoma.

    • Iron overload (thalassaemia, haemochromatosis) ➞ pituitary damage.

    • GnRH receptor mutations.

    • Endocrine antagonists: hypothyroidism, hyperprolactinaemia.

Other Endocrine Influences

  • Hypothyroidism: TRH elevation may stimulate prolactin, suppress GnRH pulses ➞ pubertal delay.

  • Hyperprolactinaemia: prolactin inhibits GnRH; prolactinomas may be micro-adenomas undetectable on imaging.

Diagnostic Work-up for Delayed or Precocious Puberty

  • Bone age X-ray (left hand/wrist): skeletal maturity vs chronological age.

  • Basal hormones:

    • IGF!−<br>1IGF!-<br>1, LH, FSH, estradiol/testosterone, DHEA-S, prolactin, TSH.

  • Dynamic tests:

    • GnRH stimulation (LH surge >5  IU/L5\;\text{IU/L} indicates activated axis).

    • GH stimulation (arginine, clonidine) if short stature.

  • Karyotype for suspected chromosomal disorders.

  • Imaging:

    • MRI brain/pituitary if gonadotropins high or suggestive lesions.

    • Pelvic/abdominal US for gonadal/adrenal mass.

Ethical, Social & Clinical Implications

  • Early or late maturation affects psychosocial well-being: self-esteem, risk-taking, bullying.

  • Advising sexual health, contraception, STI prevention essential once biologically fertile.

  • Environmental policy (endocrine disruptors) has public-health relevance.

  • Genetic counselling in familial CAH, Turner, Klinefelter, Kallmann.

  • Multidisciplinary care: endocrinologist, paediatrician, psychologist, nutritionist.

Key Equations & Numerical References

  • Puberty duration: 2≤tpuberty≤5  yrs2\le t_{puberty}\le5\;\text{yrs}.

  • Testicular enlargement threshold: Vtestes≥4  mLV_{testes}\ge4\;\text{mL} (orchidometer) or ≥2.5  cm\ge2.5\;\text{cm} length.

  • Body fat for menarche: ≈17%\approx17\%; stable menstruation ≈22%\approx22\%.

  • GnRH pulse frequency: 60–120  min60\text{–}120\;\text{min} nocturnally in early puberty.

  • Growth spurts typically occur around ages 12-14, with an average increase in height of 10-12 cm per year during peak velocity.

  • Development of secondary sexual characteristics includes increased body hair, voice changes, and skin changes associated with androgen activity. The timing and degree of these changes can vary significantly among individuals, influenced by factors such as genetics, nutrition, and environmental stressors.